Enobosarm
- Generic Name
- Enobosarm
- Drug Type
- Small Molecule
- Chemical Formula
- C19H14F3N3O3
- CAS Number
- 841205-47-8
- Unique Ingredient Identifier
- O3571H3R8N
- Background
Enobosarm has been used in trials studying the treatment of Stress Urinary Incontinence and Triple Negative Breast Cancer.
Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)
- First Posted Date
- 2015-02-23
- Last Posted Date
- 2020-11-18
- Lead Sponsor
- GTx
- Target Recruit Count
- 32
- Registration Number
- NCT02368691
- Locations
- 🇺🇸
Holy Cross Hospital, Fort Lauderdale, Florida, United States
🇺🇸US Oncology / Texas Oncology, P.A., Houston, Texas, United States
🇺🇸Lakeland Regional Health Care/Cancer Center, Lakeland, Florida, United States
Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
- Conditions
- Muscle WastingNon Small Cell Lung Cancer
- Interventions
- Drug: placebo
- First Posted Date
- 2011-05-18
- Last Posted Date
- 2016-03-03
- Lead Sponsor
- GTx
- Target Recruit Count
- 321
- Registration Number
- NCT01355484
- Locations
- 🇺🇸
GTx Investigative Site, Round Rock, Texas, United States
🇺🇸Gabrail Cancer Center, Canton, Ohio, United States
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
- Conditions
- Muscle WastingNon-Small Cell Lung Cancer
- Interventions
- Drug: placebo
- First Posted Date
- 2011-05-18
- Last Posted Date
- 2020-11-09
- Lead Sponsor
- GTx
- Target Recruit Count
- 330
- Registration Number
- NCT01355497
- Locations
- 🇺🇸
GTx Investigative Site, Round Rock, Texas, United States
🇺🇸GTx Investigator, Flat Rock, North Carolina, United States
🇺🇸Gabrail Cancer Center, Canton, Ohio, United States
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
- First Posted Date
- 2007-05-01
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- GTx
- Target Recruit Count
- 159
- Registration Number
- NCT00467844
- Locations
- 🇺🇸
Compassionate Cancer Care, Riverside, California, United States
🇺🇸Johns Hopkins University Clinical Trial Unit, Baltimore, Maryland, United States
🇺🇸Great Falls Clinic, LLP - Clinic Cancer Care, Great Falls, Montana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.